KLOW: What Is Actually in the Four-Component Peptide Blend
KLOW is a four-component research blend — GHK-Cu, BPC-157, TB-500 and KPV in one vial. Here is what each component contributes, how the copper-peptide chemistry constrains handling, and why the same product is listed here as KGLOW.
- KLOW and KGLOW are the same preparation — a four-component blend supplied in one 80 mg vial: GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg) and KPV (10 mg).
- KLOW is GLOW plus KPV: GLOW is the three-component version (GHK-Cu, BPC-157, TB-500), and the added K is the tripeptide KPV.
- Each component sits on a different pathway — matrix synthesis (GHK-Cu), cytoprotection and angiogenesis (BPC-157), actin sequestration and cell migration (TB-500), and inflammatory signalling (KPV).
- Because GHK-Cu is the majority component the reconstituted solution is blue, and the preparation must not meet acidic diluent or a chelating agent such as EDTA.
- Popular Peptides supplies it as KGLOW (80 mg), ≥98% purity, HPLC and LC-MS tested with a lot number verifiable at popularpeptides.ca/verify.
- For in vitro laboratory research use only — not approved by Health Canada for therapeutic use, and not for human or veterinary consumption.
One blend, two spellings
If you searched **KLOW**, you are in the right place. The compound is listed in this catalogue as **KGLOW** — same blend, same 80 mg vial, same lot number on the label. The spelling difference is a naming artefact, not a formulation difference, and it is worth clearing up before anything else because it sends researchers to two different sets of search results for one product.
The clearest way to read the name is as an addition. The three-component version of this blend is sold as GLOW — GHK-Cu, BPC-157 and TB-500. KLOW is that same trio with KPV added, and the leading K is the KPV.
What is in the vial
One 80 mg vial contains four compounds:
| Component | Amount | Research pathway |
|---|---|---|
| GHK-Cu | 50 mg | Copper-peptide complex; extracellular matrix gene expression |
| BPC-157 | 10 mg | Cytoprotection, angiogenic signalling |
| TB-500 (Thymosin Beta-4 fragment) | 10 mg | Actin sequestration, cell migration |
| KPV | 10 mg | Inflammatory signalling (alpha-MSH C-terminal tripeptide) |
That composition is the reason the blend exists as a single preparation rather than four separate vials: the four components sit on four distinct pathways that converge on the same tissue-repair questions, so a research model can be run against the combination without four separate reconstitutions.
GHK-Cu — the majority component
GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) bound to copper(II). It is the largest fraction of the blend by mass, and it dictates the handling rules described below.
In research settings GHK-Cu is studied for its effect on the expression of genes associated with extracellular-matrix remodelling — collagen, elastin, glycosaminoglycans — and for its role as a copper carrier in dermal cell models. It is one of the more heavily characterised peptides in dermatological research literature, which is part of why it anchors this blend.
BPC-157 — cytoprotection
BPC-157 is a synthetic pentadecapeptide derived from a sequence in human gastric juice. Preclinical research has examined it in tissue-injury models, with published work on angiogenic signalling and on interactions with nitric-oxide and growth-factor pathways. Within KLOW it contributes the cytoprotective arm.
TB-500 — cell migration
TB-500 corresponds to the active fragment of Thymosin Beta-4, a G-actin sequestering protein. Its research interest lies in actin dynamics: by binding monomeric actin it influences cytoskeletal reorganisation, which is a prerequisite for directed cell migration in wound-model research. Where GHK-Cu is studied for what cells *build*, TB-500 is studied for how they *move*.
KPV — the component that makes it KLOW
KPV is a tripeptide (lysine-proline-valine) corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone. Preclinical work has examined it for anti-inflammatory activity, including in mucosal and dermal inflammation models, and notably without the pigmentary activity of the parent hormone.
This is the single difference between GLOW and KLOW. If a research design does not need an inflammatory arm, GLOW is the narrower preparation; if it does, KLOW adds it.
Handling: copper chemistry sets the rules
Because GHK-Cu is the majority component, the reconstituted solution takes on a distinct blue colour. That is expected and is a visual confirmation that the copper complex is intact. Three constraints follow from it:
- —**No acidic diluent.** Low pH destabilises the copper complex.
- —**No chelating agents.** EDTA and similar agents will strip copper from the peptide, which is exactly the coordination this preparation depends on.
- —**Keep it dark.** Store away from light, consistent with general handling of copper-peptide preparations.
These are handling constraints on the preparation, not usage instructions. Reconstitution volumes for a research protocol can be worked out with the peptide calculator.
Verifying what you received
Blends are exactly where documentation matters most, because a four-component preparation gives four opportunities for a substitution or a short fill that a purity figure alone will not surface.
Every Popular Peptides lot is assayed by an independent laboratory — HPLC for purity, LC-MS for identity — and each vial carries a lot number. Enter it at /verify to pull the matching certificate, or browse every published lab result. Published-batch purity for this preparation is ≥98%.
Sourcing these compounds in Canada
Compounds referenced in this guide:
- —**KGLOW (KLOW)** — the full four-component blend, 80 mg
- —**GLOW** — the three-component version, without KPV
- —**GHK-Cu**, **BPC-157**, **TB-500** and **KPV** individually
These are supplied for laboratory research use and ship from within Canada — Vancouver, BC, typically 2 to 5 business days, tracked and insured. Every certificate is searchable by lot number. No customs risk, no USD conversion, free shipping over $300 CAD.
Frequently asked questions
Is KLOW the same as KGLOW?
Yes. They are two spellings of the same four-component blend. This catalogue lists it as KGLOW; a large share of search traffic uses KLOW. The vial, the composition and the certificate of analysis are identical.
What is the difference between KLOW and GLOW?
KPV. GLOW is a three-component blend (GHK-Cu, BPC-157, TB-500). KLOW is the same three plus 10 mg of KPV, which adds an inflammatory-signalling component to the research profile.
Why is the reconstituted solution blue?
GHK-Cu is a copper(II) complex and is the majority component by mass. The blue colour is the copper coordination and is expected. Loss of colour suggests the complex has been disrupted — most commonly by acidic diluent or a chelating agent.
Can I buy KLOW in Canada?
Popular Peptides ships KGLOW (KLOW) domestically from Vancouver, BC, for laboratory research use only. Because it ships within Canada there is no customs step, no brokerage fee and no USD conversion.
What purity is it?
Published batches assay at ≥98% by HPLC, with identity confirmed by LC-MS at an independent third-party laboratory. The batch-specific certificate is available on request and each lot number is verifiable at /verify.
---
KGLOW (KLOW) is supplied for in vitro laboratory research use only. It is not approved by Health Canada for therapeutic use, is not a treatment for any condition, and is not intended for human or veterinary consumption. 18+.
Every batch we sell is independently third-party tested, with the full Certificate of Analysis published and checkable by lot number.